|
1
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bhowmick NA, Neilson EG and Moses HL:
Stromal fibroblasts in cancer initiation and progression. Nature.
432:332–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Robinson BD, Sica GL, Liu YF, Rohan TE,
Gertler FB, Condeelis JS and Jones JG: Tumor microenvironment of
metastasis in human breast carcinoma: A potential prognostic marker
linked to hematogenous dissemination. Clin Cancer Res.
15:2433–2441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tlsty TD and Coussens LM: Tumor stroma and
regulation of cancer development. Annu Rev Pathol. 1:119–150. 2006.
View Article : Google Scholar
|
|
5
|
Andò S and Catalano S: The multifactorial
role of leptin in driving the breast cancer microenvironment. Nat
Rev Endocrinol. 8:263–275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo S, Liu M, Wang G, Torroella-Kouri M
and Gonzalez-Perez RR: Oncogenic role and therapeutic target of
leptin signaling in breast cancer and cancer stem cells. Biochim
Biophys Acta. 1825:207–222. 2012.PubMed/NCBI
|
|
7
|
Andò S, Barone I, Giordano C, Bonofiglio D
and Catalano S: The multifaceted mechanism of Leptin signaling
within tumor microenvironment in driving breast cancer growth and
progression. Front Oncol. 4:3402014.PubMed/NCBI
|
|
8
|
Procaccini C, Jirillo E and Matarese G:
Leptin as an immuno-modulator. Mol Aspects Med. 33:35–45. 2012.
View Article : Google Scholar
|
|
9
|
Oswal A and Yeo G: Leptin and the control
of body weight: A review of its diverse central targets, signaling
mechanisms, and role in the pathogenesis of obesity. Obesity
(Silver Spring). 18:221–229. 2010. View Article : Google Scholar
|
|
10
|
Gainsford T, Willson TA, Metcalf D,
Handman E, McFarlane C, Ng A, Nicola NA, Alexander WS and Hilton
DJ: Leptin can induce proliferation, differentiation, and
functional activation of hemopoietic cells. Proc Natl Acad Sci USA.
93:14564–14568. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zarkesh-Esfahani H, Pockley G, Metcalfe
RA, Bidlingmaier M, Wu Z, Ajami A, Weetman AP, Strasburger CJ and
Ross RJ: High-dose leptin activates human leukocytes via receptor
expression on monocytes. J Immunol. 167:4593–4599. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mattioli B, Straface E, Quaranta MG,
Giordani L and Viora M: Leptin promotes differentiation and
survival of human dendritic cells and licenses them for Th1
priming. J Immunol. 174:6820–6828. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chanmee T, Ontong P, Konno K and Itano N:
Tumor-associated macrophages as major players in the tumor
microenvironment. Cancers (Basel). 6:1670–1690. 2014. View Article : Google Scholar
|
|
14
|
Faggioni R, Fantuzzi G, Gabay C, Moser A,
Dinarello CA, Feingold KR and Grunfeld C: Leptin deficiency
enhances sensitivity to endotoxin-induced lethality. Am J Physiol.
276:R136–R142. 1999.PubMed/NCBI
|
|
15
|
Lee FY, Li Y, Yang EK, Yang SQ, Lin HZ,
Trush MA, Dannenberg AJ and Diehl AM: Phenotypic abnormalities in
macrophages from leptin-deficient, obese mice. Am J Physiol.
276:C386–C394. 1999.PubMed/NCBI
|
|
16
|
Gordon S: The macrophage: Past, present
and future. Eur J Immunol. 37(Suppl 1): S9–S17. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mosser DM and Edwards JP: Exploring the
full spectrum of macrophage activation. Nat Rev Immunol. 8:958–969.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mantovani A, Sica A, Sozzani S, Allavena
P, Vecchi A and Locati M: The chemokine system in diverse forms of
macrophage activation and polarization. Trends Immunol. 25:677–686.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ojalvo LS, King W, Cox D and Pollard JW:
High-density gene expression analysis of tumor-associated
macrophages from mouse mammary tumors. Am J Pathol. 174:1048–1064.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Woldbaek PR, Tønnessen T, Henriksen UL,
Florholmen G, Lunde PK, Lyberg T and Christensen G: Increased
cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial
infarction in the mouse; a potential role in cardiac dysfunction.
Cardiovasc Res. 59:122–131. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Colston JT, Boylston WH, Feldman MD,
Jenkinson CP, de la Rosa SD, Barton A, Trevino RJ, Freeman GL and
Chandrasekar B: Interleukin-18 knockout mice display maladaptive
cardiac hypertrophy in response to pressure overload. Biochem
Biophys Res Commun. 354:552–558. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dinarello CA: Interleukin-18. Methods.
19:121–132. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Y, Hahm E, Kim Y, Kang J, Lee W, Han
I, Myung P, Kang H, Park H and Cho D: Regulation of IL-18
expression by CRH in mouse microglial cells. Immunol Lett.
98:291–296. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vidal-Vanaclocha F, Mendoza L, Telleria N,
Salado C, Valcárcel M, Gallot N, Carrascal T, Egilegor E,
Beaskoetxea J and Dinarello CA: Clinical and experimental
approaches to the pathophysiology of interleukin-18 in cancer
progression. Cancer Metastasis Rev. 25:417–434. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim KE, Song H, Kim TS, Yoon D, Kim CW,
Bang SI, Hur DY, Park H and Cho DH: Interleukin-18 is a critical
factor for vascular endothelial growth factor-enhanced migration in
human gastric cancer cell lines. Oncogene. 26:1468–1476. 2007.
View Article : Google Scholar
|
|
26
|
Mantovani A, Sica A, Sozzani S, Allavena
P, Vecchi A and Locati M: The chemokine system in diverse forms of
macrophage activation and polarization. Trends Immunol. 25:677–686.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Daigneault M, Preston JA, Marriott HM,
Whyte MK and Dockrell DH: The identification of markers of
macrophage differentiation in PMA-stimulated THP-1 cells and
monocyte-derived macrophages. PLoS One. 5:e86682010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qualls JE, Kaplan AM, van Rooijen N and
Cohen DA: Suppression of experimental colitis by intestinal
mononuclear phagocytes. J Leukoc Biol. 80:802–815. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Van Rooijen N and Sanders A: Liposome
mediated depletion of macrophages: Mechanism of action, preparation
of liposomes and applications. J Immunol Methods. 174:83–93. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang X: Tumor-associated macrophages as
potential diagnostic and prognostic biomarkers in breast cancer.
Cancer Lett. 332:3–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Newman G and Gonzalez-Perez RR:
Leptin-cytokine crosstalk in breast cancer. Mol Cell Endocrinol.
382:570–582. 2014. View Article : Google Scholar
|
|
32
|
Yang Y, Cheon S, Jung MK, Song SB, Kim D,
Kim HJ, Park H, Bang SI and Cho D: Interleukin-18 enhances breast
cancer cell migration via down-regulation of claudin-12 and
induction of the p38 MAPK pathway. Biochem Biophys Res Commun.
459:379–386. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lewis C and Murdoch C: Macrophage
responses to hypoxia: Implications for tumor progression and
anti-cancer therapies. Am J Pathol. 167:627–635. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun B, Nishihira J, Yoshiki T, Kondo M,
Sato Y, Sasaki F and Todo S: Macrophage migration inhibitory factor
promotes tumor invasion and metastasis via the Rho-dependent
pathway. Clin Cancer Res. 11:1050–1058. 2005.PubMed/NCBI
|
|
35
|
De Palma M and Lewis CE: Macrophage
regulation of tumor responses to anticancer therapies. Cancer Cell.
23:277–286. 2013. View Article : Google Scholar : PubMed/NCBI
|
